Crowne Plaza Geneva, Switzerland | 14 - 15 May 2025 | Booth #21
TCS ADD™ Connected Clinical Trial platform received recognition for providing a unified, next-gen patient and site-centric offering
Improved data quality and oversight
Quicker decision-making
Meaningful insights and preventive intervention
Faster drug registration process
Pharma organizations need to enable informed, engaged, and connected clinical trials that are patient-centric and site-friendly.
The siloed, convoluted, and cumbersome clinical trial processes levied immense operational burdens on sites, sponsors, and CROs, thus preventing them from executing trials effectively. Disparate systems have resulted in manual, paper-based, time-consuming, and error-prone processes resulting in delayed trial timelines.
TCS ADD™ Connected Clinical Trials provides a unified interface for patients and sites and incorporates smart, intuitive, futuristic, cloud-based technologies and collaborations to enable next-generation patient-centric trials.
14+ Patents | 19+ Global customers | 700+ Trials supported | 50K+ Sites onboarded | 100% Regulatory compliant |
TCS helped Roche roll out an eConsent solution
An industry-first unified platform for clinical supply management that brings together kit tracking, unit dose tracking, and digital labels supporting direct-to-patient and traditional supply models.
Highly configurable solution with a rich library of personalized and multimedia engagement tools
Secure, end-to-end consent solution supporting paper-based and e-signature; embedded with multimedia engagement tools
Device-agnostic, seamless, multi-tenant, and feature-rich televisit functionality for patients, sites, and sponsors
Biometric sensors with connected medical devices for timely and accurate health insights through automated data collection and remote monitoring
Personalized patient and site support throughout the trial process via portals, apps, and multimedia literature
Modern technologies, deep contextual expertise, and close collaboration with pharma organizations, patient advocacy groups, regulatory bodies, clinicians, and others alike combined with an ability to support adaptive (virtual, traditional, and hybrid) studies make TCS ADD™ Connected Clinical Trials, our decentralized trials platform, a preferred choice for trials worldwide.
